Expanding the Therapeutic Window of EGFR-Targeted PE24 Immunotoxin for EGFR-Overexpressing Cancers by Tailoring the EGFR Binding AffinitySei-Yong Jun(Ajou University), Yong‐Sung Kim(Ajou University)International Journal of Molecular SciencesDecember 13, 202210.3390/ijms232415820Cited by 16SaveCiteExport RISWatch citationsRelated PapersProduction of recombinant human procollagen type I C-terminal propeptide and establishment of a sandwich ELISA for quantification|Scientific Reports|2017|44Supplementary Figures S1-S5; Supplementary Tables S1-S4; and Supplementary Materials & Methods from A Heterodimeric Fc-Based Bispecific Antibody Simultaneously Targeting VEGFR-2 and Met Exhibits Potent Antitumor Activity|Unknown|2023|0